男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)

High Sensitive ELISA Kit for Alpha-1-Acid Glycoprotein (a1AGP)

AGP1; a1-AGP; ORM1; OMD 1; Orosomucoid 1

  • α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)產(chǎn)品包裝(模擬)
  • α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)產(chǎn)品包裝(模擬)
  • α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)實(shí)驗(yàn)結(jié)果圖
  • HEA816Hu.jpg標(biāo)準(zhǔn)曲線圖
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

本試劑盒用于檢測(cè)α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型),經(jīng)檢測(cè)與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。

回收率

分別于定值血清及血漿樣本中加入一定量的α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。

樣本回收率范圍(%)平均回收率(%)
serum(n=5)97-104101
EDTA plasma(n=5)86-10192
heparin plasma(n=5)80-9590

精密度

精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)含量的測(cè)定值與理論值的比率。

樣本1:21:41:81:16
serum(n=5)84-98%79-90%87-94%96-103%
EDTA plasma(n=5)83-97%98-105%97-104%87-96%
heparin plasma(n=5)98-105%92-101%80-104%95-105%

穩(wěn)定性

經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。

實(shí)驗(yàn)流程

1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測(cè)溶液A100µL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分鐘;
8. 加終止液50µL,立即450nm讀數(shù)。

實(shí)驗(yàn)原理

將α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)呈正相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度(O.D.值),計(jì)算樣品濃度。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA816Hu01α1-酸性糖蛋白(a1AGP)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA816Hu01α1-酸性糖蛋白(a1AGP)多克隆抗體WB
PAA816Hu02α1-酸性糖蛋白(a1AGP)多克隆抗體WB; IHC; ICC; IP; FCM
LAA816Hu71α1-酸性糖蛋白(a1AGP)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAA816Hu24α1-酸性糖蛋白(a1AGP)單克隆抗體WB; IHC; ICC; IP.
MAA816Hu21α1-酸性糖蛋白(a1AGP)單克隆抗體WB; IHC
MAA816Hu25α1-酸性糖蛋白(a1AGP)單克隆抗體WB; IHC; ICC; IP.
MAA816Hu22α1-酸性糖蛋白(a1AGP)單克隆抗體WB,IHC
MAA816Hu23α1-酸性糖蛋白(a1AGP)單克隆抗體WB; IHC; ICC; IP.
FAA816Hu02抗α1-酸性糖蛋白(a1AGP)單克隆抗體Flow cytometry.
LAA816Hu72α1-酸性糖蛋白(a1AGP)單克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
SEA816Huα1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
HEA816Huα1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA816Huα1-酸性糖蛋白(a1AGP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSA816Hu01α1-酸性糖蛋白(a1AGP)抗體對(duì)ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA816Hu01α1-酸性糖蛋白(a1AGP)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
J Reprod Dev.?An Acute-phase Protein as a Regulator of Sperm Survival in the Bovine Oviduct: Alpha 1-acid-glycoprotein Impairs Neutrophil Phagocytosis of Sperm In Vitro[Pubmed:Pmc4219990]
Molecular Reproduction and DevelopmentEvidence for a novel, local acute-phase response in the bovine oviduct: Progesterone and lipopolysaccharide up-regulate alpha 1-acid-glycoprotein expression in epithelial cells in vitro[Pubmed:25123565]
BMC Complementary and Alternative MedicineIdentification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study[Pubmed:25652121]
PLoS OneGut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study[PubMed: 25955845]
Sci Rep.?S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine[pmc:PMC4810364]
Journal of Chromatography AApplication of a new procedure for liquid chromatography/mass spectrometry profiling of plasma amino acid-related metabolites and untargeted shotgun proteomics to identify mechanisms and biomarkers of calcific aortic stenosis[S0021967317311858]
Scientific ReportsAn autoregressive logistic model to predict the reciprocal effects of oviductal fluid components on in vitro spermophagy by neutrophils in cattle[pubmed:28667317]
33Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.[pubmed:28927749]
Brazilian Journal of OtorhinolaryngologyInflammatory markers in palatine tonsils of children with obstructive sleep apnea syndrome[Pubmed: 30213594]
BioRxivProteome-wide characterization and biomarker identification of intracranial aneurysm[]
The FEBS journalDramatically changed immune‐related molecules as early diagnostic biomarkers of non‐small cell lung cancer[Pubmed: 31482685]
PLoS OneEffects of vaccination on acute-phase protein response in broiler chicken[Pubmed: 32191767]
Indian Journal of Animal SciencesPeripheral concentrations of metabolic and inflammatory indicators during transition period and their relationship with postpartum clinical endometritis in dairy?…[]
A New Biomarker Tool for Risk Stratification in ?°De Novo?± Acute Heart Failure (OROME)[]